Brief: Sprint Bioscience AB Gets Financing From The Swedish Foundation For Strategic Research
Oct 21 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* GETS FINANCING FROM THE SWEDISH FOUNDATION FOR STRATEGIC RESEARCH FOR THE IDENTIFICATION
OF NEW
MEDICINE TARGETS IN THE TREATMENT OF BLOOD CANCER
Source text for Eikon: ID:nWkrbfDjF3
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program